• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by The Cigna Group

    3/13/26 4:39:25 PM ET
    $CI
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email
    DEFA14A 1 ef20067624_defa14a.htm DEFA14A

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a) of
    the Securities Exchange Act of 1934 (Amendment No.   )

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant  ☐

    Check the appropriate box:

    ☐ Preliminary Proxy Statement
       
    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
       
    ☐ Definitive Proxy Statement
       
    ☒ Definitive Additional Materials
       
    ☐ Soliciting Material under § 240.14a-12

    The Cigna Group
    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check all boxes that apply):

    ☒ ​No fee required


    ☐ ​Fee paid previously with preliminary materials


    ☐ ​Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11



     Your Vote Counts!  *Please check the meeting materials for any special requirements for meeting attendance.  Smartphone users  Point your camera here and vote without entering a control number  For complete information and to vote, visit www.ProxyVote.com  Control #  V83626-P42812-Z91840  THE CIGNA GROUP C/O PROXY SERVICES  P.O. BOX 9142  FARMINGDALE, NY 11735  The Cigna Group  2026 Annual Meeting  Vote by April 21, 2026 11:59 p.m. ET or at the meeting  You invested in The Cigna Group and it’s time to vote!  You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the  availability of proxy materials for the shareholder meeting to be held on April 22, 2026.  Get informed before you vote.  View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the materials by  requesting such materials prior to April 8, 2026. If you would like to request a copy of the materials for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com; (2) call 1-800-579-1639; or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or an email copy.  Vote virtually at the meeting*  April 22, 2026  11:00 a.m. ET  Virtually at: www.virtualshareholdermeeting.com/CI2026 
     

     Vote at www.ProxyVote.com  THIS IS NOT A VOTABLE BALLOT.  This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote on these important matters. The proxy materials are available to you on the Internet. You may view these materials online at www.proxyvote.com or request a paper or an email copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting.  Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”.  1. Election of Directors:  1a. David M. Cordani  For  1b.  Brian C. Evanko  For  1c.  Eric J. Foss  For  1d.  Neesha Hathi  For  1e.  Michael J. Hennigan  For  1f.  George Kurian  For  1g.  Kathleen M. Mazzarella  For  1h.  Mark B. McClellan, M.D., Ph.D.  For  1i.  Philip O. Ozuah, M.D., Ph.D.  For  1j.  Kimberly A. Ross  For  1k.  Eric C. Wiseman  For  1l.  Donna F. Zarcone  For  2. Advisory approval of executive compensation  For  3. Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group’s independent registered public accounting firm for 2026  For  4. Shareholder Proposal — Shareholder Right to Act by Written Consent  Against  Note: Such other business as may properly come before the meeting or any postponements or adjournments thereof  Our board has fixed the close of business on February 23, 2026 as the record date for the determination of shareholders entitled to notice of, and to vote at, the meeting and any adjournments thereof. A list of shareholders will be made available to shareholders during ordinary business hours for a period of at least ten days ending on the day before the meeting date at www.virtualshareholdermeeting.com/CI2026.  Voting Items  Board Recommends  V83627-P42812-Z91840 
     

    Get the next $CI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI

    DatePrice TargetRatingAnalyst
    5/26/2026$304.00Overweight → Equal Weight
    Barclays
    5/20/2026$302.00Buy → Hold
    Deutsche Bank
    3/12/2026$358.00Mkt Perform → Outperform
    Bernstein
    10/14/2025$370.00Buy
    Goldman
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    6/26/2024$400.00Overweight
    Piper Sandler
    5/30/2024$388.00Outperform
    Robert W. Baird
    3/6/2024$393.00Overweight
    Barclays
    More analyst ratings

    $CI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Cigna Group downgraded by Barclays with a new price target

    Barclays downgraded The Cigna Group from Overweight to Equal Weight and set a new price target of $304.00

    5/26/26 8:44:05 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded The Cigna Group from Buy to Hold and set a new price target of $302.00

    5/20/26 8:05:39 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group upgraded by Bernstein with a new price target

    Bernstein upgraded The Cigna Group from Mkt Perform to Outperform and set a new price target of $358.00

    3/12/26 8:38:26 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Cigna Group's Second Quarter 2026 Earnings Release Details

    BLOOMFIELD, Conn., July 7, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2026 financial results on Thursday, July 30, 2026, and will host a conference call the same day. Second quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:             Live Call             (888) 566-1889 (Domestic)             (773) 799-3989 (International)             Passcode: 07302026             Replay             (866) 405-7290 (Domestic) 

    7/7/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Evernorth Launches Pharmacy Forward: A Simpler, Faster Specialty Pharmacy Experience for Patients Managing Complex Conditions

    New program introduces AI-enabled capabilities to personalize support, streamline prescription processing, and help patients start and stay on therapy with greater ease and confidenceBLOOMFIELD, Conn., July 1, 2026 /PRNewswire/ -- As specialty care becomes more complex, patients need faster, more connected, and personalized support. To help meet that need, Evernorth, the health services division of The Cigna Group (NYSE:CI), today unveiled Pharmacy Forward, a new AI-powered program designed to improve how patients access and experience specialty care. Launching first with Accredo Specialty Pharmacy – which serves patients with chronic and complex specialty conditions through condition-specif

    7/1/26 8:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Foundation Honors David M. Cordani's Leadership with New Grant to Strengthen Military Communities

    New "Courage in Service" grant builds on company's long-standing support for military and veteran communities.BLOOMFIELD, Conn., June 25, 2026 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE:CI), today announced the launch of the David M. Cordani Courage in Service Grant, a new $1.5 million, 10-year commitment to support the health and well-being of military and veteran communities by prioritizing social connection. The grant comes as Cordani, who has served as chief executive officer of The Cigna Group for 17 years, is set to retire as

    6/25/26 10:14:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Holgerson Bryan claimed ownership of 7,693 shares (SEC Form 3)

    3 - Cigna Group (0001739940) (Issuer)

    7/9/26 7:36:18 PM ET
    $CI
    Medical Specialities
    Health Care

    New insider Kautzner Adam claimed ownership of 13,533 shares (SEC Form 3)

    3 - Cigna Group (0001739940) (Issuer)

    7/9/26 7:34:58 PM ET
    $CI
    Medical Specialities
    Health Care

    New insider Sadler Jason D claimed ownership of 34,705 shares (SEC Form 3)

    3 - Cigna Group (0001739940) (Issuer)

    7/9/26 7:33:43 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    SEC Filings

    View All

    SEC Form 11-K filed by The Cigna Group

    11-K - Cigna Group (0001739940) (Filer)

    6/24/26 4:27:09 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Cigna Group (0001739940) (Filer)

    5/13/26 6:01:44 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    5/12/26 4:18:20 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Cordani David bought $999,916 worth of shares (4,134 units at $241.88) (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    11/3/25 2:47:56 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Financials

    Live finance-specific insights

    View All

    The Cigna Group's Second Quarter 2026 Earnings Release Details

    BLOOMFIELD, Conn., July 7, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2026 financial results on Thursday, July 30, 2026, and will host a conference call the same day. Second quarter 2026 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:             Live Call             (888) 566-1889 (Domestic)             (773) 799-3989 (International)             Passcode: 07302026             Replay             (866) 405-7290 (Domestic) 

    7/7/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Reports Strong First Quarter 2026 Results, Raises 2026 Outlook

    Total revenues for the first quarter 2026 increased 5% to $68.5 billionShareholders' net income for the first quarter 2026 was $1.7 billion, or $6.26 per shareAdjusted income from operations1 for the first quarter 2026 was $2.1 billion, or $7.79 per share2026 outlook2 for adjusted income from operations1,2 increased to at least $30.35 per share2BLOOMFIELD, Conn., April 30, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported first quarter 2026 results, reflecting growth across its diversified portfolio of businesses."We continue to improve how people experience health care, leveraging innovation and technology to make it more personalized, more transparent and

    4/30/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Declares Quarterly Dividend

    BLOOMFIELD, Conn., April 22, 2026 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.56 per share of its common stock, payable on June 18, 2026, to shareholders of record as of the close of business on June 4, 2026. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services mar

    4/22/26 4:30:00 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Leadership Updates

    Live Leadership Updates

    View All

    The Cigna Group Foundation Honors David M. Cordani's Leadership with New Grant to Strengthen Military Communities

    New "Courage in Service" grant builds on company's long-standing support for military and veteran communities.BLOOMFIELD, Conn., June 25, 2026 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE:CI), today announced the launch of the David M. Cordani Courage in Service Grant, a new $1.5 million, 10-year commitment to support the health and well-being of military and veteran communities by prioritizing social connection. The grant comes as Cordani, who has served as chief executive officer of The Cigna Group for 17 years, is set to retire as

    6/25/26 10:14:00 AM ET
    $CI
    Medical Specialities
    Health Care

    Kayne Anderson Energy Infrastructure Fund Announces Appointment of Michael J. Hennigan as New Independent Director

    HOUSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company" or "KYN") announced today the appointment of Michael J. Hennigan as an independent director of the Company, effective immediately. Following the retirements of William R. Cordes and Barry R. Pearl earlier this year, the appointment of Mr. Hennigan brings the Company's Board to six members, five of whom are independent. Michael J. Hennigan is a highly accomplished energy executive, with several decades of leadership experience in the refining and midstream sectors. Mr. Hennigan most recently served as Executive Chairman of Marathon Petroleum Corporation (NYSE:MPC) and MPLX LP (NYSE:MPLX

    5/12/26 4:20:00 PM ET
    $CI
    $KYN
    $MPC
    Medical Specialities
    Health Care
    Finance/Investors Services
    Finance

    The Cigna Group Announces President & COO Brian Evanko to Succeed David M. Cordani as Chief Executive Officer

    Cordani to retire as chief executive officer on July 1, 2026, and will serve as executive chair of The Cigna Group Board of DirectorsEvanko elected to the company's Board of DirectorsCompany reaffirms 2026 Financial OutlookBLOOMFIELD, Conn., March 3, 2026 /PRNewswire/ -- The Cigna Group (NYSE: CI) today announced that David M. Cordani will retire as chief executive officer effective July 1, 2026, and become executive chair of The Cigna Group's Board of Directors. Brian Evanko, current president and chief operating officer, will succeed Cordani as CEO. Throughout his tenure—inclu

    3/3/26 7:30:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by The Cigna Group

    SC 13G - Cigna Group (0001739940) (Subject)

    11/12/24 9:55:14 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/13/24 5:02:29 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/9/24 8:50:20 AM ET
    $CI
    Medical Specialities
    Health Care